Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine

Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine

DSpace/Manakin Repository

Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Greilsamer, Glenn J.	en_US
dc.date.accessioned	2012-06-07T20:13:14Z
dc.date.issued	2002	en_US
dc.identifier.citation	Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine (2002 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852124
dc.description.abstract	This paper explores the various impediments to the development of a safe and effective AIDS vaccine, and offers suggestions to help overcome these obstacles. I begin by discussing the FDA approval process and the current state of AIDS vaccine development. I then consider the different scientific impediments to the development of a preventive vaccine. The next section addresses the logistical and ethical issues in the clinical testing of a vaccine. I discuss the ethical principles that should guide researchers, demonstrate the social harm that participation may cause volunteers, and suggest methods to resolve these ethical dilemmas. Finally, I discuss the economic impediments faced by manufacturers in the form of high costs, uncertain profit margins, and unpredictable liability. Using past legislative attempts at restructuring manufacturer incentives as models, I present recommendations to help encourage manufacturers to produce the safest and most effective vaccine they can, and make it available as quickly as possible.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	AIDS	en
dc.subject	vaccine	en
dc.subject	development	en
dc.title	Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T20:13:14Z